The Effects of Disease-Modifying Anti-Rheumatic Drugs on Total Hip Arthroplasty Outcomes in Patients Who Have Inflammatory Arthropathies. Journal Abstract - Guideline Central

The Effects of Disease-Modifying Anti-Rheumatic Drugs on Total Hip Arthroplasty Outcomes in Patients Who Have Inflammatory Arthropathies.

Published: 2026 Apr 17

Authors

, , , , , , ,

Abstract

Disease-modifying anti-rheumatic drugs (DMARDs) are essential in managing inflammatory arthritides such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and juvenile idiopathic arthritis (JIA). As total hip arthroplasty (THA) and DMARD use become more common, it is unclear how DMARD use affects outcomes in this population. This study compared complications and implant survivorship after THA in patients who have inflammatory arthritis who had and did not have DMARD treatment.

Keywords: Anti-Rheumatic Drugs, Arthropathy, Level of Evidence: III, Outcomes, Total Hip Arthroplasty

Source

The Journal of arthroplasty

Publication Type

Journal Article

Language

English

PubMed ID

42001906

You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.